Acceso abdominal y acceso transanal
Palabras clave:
cáncer de recto, Cirugía colorrectalResumen
Artículo especial: capítulo 8 de la “Guía práctica para el tratamiento quirúrgico del cáncer de recto" del Grupo Gallego de Coloproctología y la Sociedad de Cirugía de Galicia.
Descargas
Citas
Guillou P. J., Quirke P., Thorpe H., Walker J., Jayne D. G., Smith A. M., et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet. 2005; 365:1718-26. Doi: 10.1016/S0140-6736(05)66545-2.
Jayne D. G., Guillou P. J., Thorpe H., Quirke P., Copeland J., Smith A. M., et al. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol. 2007; 25:3061-8. Doi: 10.1200/JCO.2006.09.7758.
Vennix S., Pelzers L., Bouvy N., Beets G. L., Pierie J. P., Wiggers T., et al. Laparoscopic versus open total mesorectal excision for rectal cancer. Cochrane Database Syst Rev.2014; 15:CD005200. Doi: 10.1002/14651858.CD005200.
Park J. W., Kang S. B., Hao J., Lim S. B., Choi H. S., Kim D. W., et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): 10-year follow-up of an open-label, non-inferiority, randomised controlled trial. Lancet Gastroenterol Hepatol. 2021; 6:569-577. Doi: 10.1016/S2468-1253(21)00094-7.
Stevenson A. R., Solomon M. J., Lumley J. W., Hewett P., Clouston A. D., Gebski V. J., et al. Effect of Laparoscopic-Assisted Resection vs. Open Resection on Pathological Outcomes in Rectal Cancer: The ALaCaRT Randomized Clinical Trial. JAMA. 2015 6; 314:1356- 63. Doi: 10.1001/jama.2015.12009.
Fleshman J., Branda M., Sargent D. J., Boller A. M., George V., Abbas M., et al. Effect of Laparoscopic-Assisted Resection vs. Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial. JAMA. 2015; 314:1346-55. Doi: 10.1001/jama.2015. 10529.
Fleshman J., Branda M. E., Sargent D. J., Boller A. M., George V. V., Abbas M. A., et al. Disease-free Survival and Local Recurrence for Laparoscopic Resection Compared With Open Resection of Stage II to III Rectal Cancer: Follow-up Results of the ACOSOG Z6051 Randomized Controlled Trial. Ann Surg. 2019; 269:589-595. Doi: 10.1097/SLA.00 00000000003002.
Lim W. H., Tan D. J. H., Ng C. H., Syn N., Tai B. C., Gu T., et al. Laparoscopic versus open resection for rectal cancer: An individual patient data meta analysis of randomized controlled trials. Eur J Surg Oncol. 2022; 48:1133-43. Doi: 10.1016/j.ejso. 2021.11.012.
Creavin B., Kelly M. E., Ryan É. J., Ryan O. K., Winter D. C. Oncological outcomes of laparoscopic versus open rectal cancer resections: meta-analysis of randomized clinical trials. Br J Surg. 2021; 108:469-76. Doi: 10.1093/bjs/znaa154.
Kong M., Chen H., Shan K., Sheng H., Li L. Comparison of Survival Among Adults With Rectal Cancer Who Have Undergone Laparoscopic vs. Open Surgery: A Meta-analysis. JAMA Netw Open. 2022; 5:e2210861. Doi: 10.1001/jamanet workopen.2022.10861.
Feng Q., Yuan W., Li T., Tang B., Jia B., Zhou E., et al. REAL Study Group. Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial. Lancet Gastroenterol Hepatol. 2022; 7: 991-1004. Doi: 10.1016/S2468-1253(22)00248-5.
Roh H. F., Nam S. H., Kim J. M. Robot-assisted laparoscopic surgery versus conventional laparoscopic surgery in randomized controlled trials: A systematic review and meta-analysis. PLoS One. 2018; 13: e0191628. Doi: 10.1371/journal.pon.0191628.
Guo E., Guo E., Luo E., Song X., Zhao H., Li L. Comparison of pathologic outcomes of robotic and open resections for rectal cancer: A systematic review and meta-analysis. PLoS One. 2021; 16: e0245154. Doi: 10.1371/journal.pon.0245154.
Jayne D., Pigazzi A., Marshall H., Croft J., Corrigan N., Copeland J., et al. Robotic-assisted surgery compared with laparoscopic resection surgery for rectal cancer: the ROLARR RCT. Efficacy Mech Eval 2019; 6(10) doi: 10.3310/eme06100.
Penna M., Cunningham C., Hompes R. Transanal Total Mesorectal Excision: Why, When, and How. Clin Colon Rectal Surg. 2017; 30:339-345. Doi: 10.1055/s-0037-1606111.
Koedam T. W. A., Veltcamp Helbach M., van de Ven P. M., Kruyt P. M., van Heek N. T., Bonjer H. J., Tuynman J. B., Sietses C. Transanal total mesorectal excision for rectal cancer: evaluation of the learning curve. Tech Coloproctol. 2018; 22:279-87. Doi: 10.1007/s10151-018-1771-8.
Francis N., Penna M., Mackenzie H., Carter F., Hompes R. International TaTME Educational Collaborative Group. Consensus on strutured training curriculum for transanal total mesorectal excision (TaTME). Surg Endosc. 2017; 31:2711-9. Doi: 10.1007/s00464-017-5562-5.
Zhang X., Gao E., Dai X., Zhang H., Cheng X., Li Q., et al. Comparison of short- and long-term outcomes between laparoscope-assisted transanal total mesorectal excision and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: a meta-analysis. Zhonghua Wei Chang Wai Ke Za Zhi. 2018; 21:924-35. Chinese.
Ma B., Gao P., Song E., Zhang C., Zhang C., Wang L., et al. Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision. BMC Cancer. 2016; 16:380. Doi: 10.1186/s12885-016-2428-5.
Xu W., Xu Z., Cheng H., Ying J., Cheng F., Xu W., et al. Comparison of short-term clinical outcomes between transanal and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: A meta-analysis. Eur J Surg Oncol. 2016; 42:1841-50. Doi: 10.1016/j.ejso. 2016.09.002.
Lei P., Ruan E., Yang X., Fang J., Chen T. Trans-anal or trans-abdominal total mesorectal excision? A systematic review and meta-analysis of recent comparative studies on perioperative outcomes and pathological result. Int J Surg. 2018; 60:113-9. Doi: 10.1016/j.ijsu.2018.11.003.
Aubert M., Mege D., Panis E. Total mesorectal excision for low and middle rectal cancer: laparoscopic versus transanal approach-a meta-analysis. Surg Endosc. 2020; 34:3908-9. Doi: 10.1007/s00464-019-07160-8.
Roodbeen S. X., Spinelli A., Bemelman W. A., Di Candido F., Cardepont M., Denost Q., et al. Local Recurrence After Transanal Total Mesorectal Excision for Rectal Cancer: A Multicenter Cohort Study. Ann Surg. 2021; 274: 359-66. Doi: 10.1097/SLA.0000000000003757.
Larsen S. G., Pfeffer F., Kørner H. Norwegian Colorectal Cancer Group. Norwegian moratorium on transanal total mesorectal excision. Br J Surg. 2019; 106:1120-1. Doi: 10.1002/bjs.11287.
Milone M., Adamina M., Arezzo A., Bejinariu N., Boni L., Bouvy N., et al. UEG and EAES rapid guideline: Systematic review, meta-analysis, GRADE assessment and evidence-informed European recommendations on TaTME for rectal cancer. Surg Endosc. 2022; 36:2221-32. Doi: 10.1007/s00464-022-09090-4.
Lelong B., de Chaisemartin C., Meillat H., Cournier S., Boher J. M., Genre D., et al. A multicentre randomised controlled trial to evaluate the efficacy, morbidity and functional outcome of endoscopic transanal proctectomy versus laparoscopic proctectomy for low-lying rectal cancer (ETAP-GRECCAR 11 TRIAL): rationale and design. BMC Cancer. 2017; 17:253. Doi: 10.1186/s12885-017-3200-1.
Deijen C. L., Velthuis S., Tsai A., Mavroveli S., de Lange-de Klerk E. S., Sietses C., et al. COR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer. Surg Endosc. 2016; 30:3210-5. Doi: 10.1007/s00464-015-4615-x.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2026 A. Piñeiro Teijeiro, E. Moncada Iribarren
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
